In Norwegian
Node leaders: Kristoffer Haugarvoll and Ragnhild Eide Skogseth
Kristoffer Haugarvoll, MD, PhD is principal investigator (PI) in the Bergen Dementia Research Group, Associate Professor at the University of Bergen and a consultant neurologist at the Department of Neurology, Haukeland University Hospital. Dr. Haugarvoll’s clinical expertise includes neurodegeneration, movement disorders, dementia, and neurogenetics. His main research focus is dementia and neurodegeneration in particular dementia related to Alzheimer’s disease (AD), dementia with Lewy bodies (DLB) and the Parkinson’s disease dementia (PDD) spectrum.
Ragnhild Eide Skogseth, MD PhD, is an associate professor at the University of Bergen and a consultant geriatrician and principal investigator (PI) for dementia studies at Haraldsplass Deaconess Hospital. Dr Skogseth’s clinical expertise includes neurodegeneration, dementia and biomarkers. Her main research focus is dementia and neurodegeneration in particular dementia related to Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB), and novel biomarkers to better diagnose these diseases.
Additional key node partner is Bettina Husebø, who is also leader of the Care Node.
Node activities
Motivated by the promising finding of NAD replenishment therapy in PD, the Dementia Node has initiated clinical treatment studies to assess the neuroprotective potential of NAD supplementation in Alzheimer’s disease. In addition, they conduct state-of-the-art biomarker research aiming at identifying subtypes of individuals with dementia, including AD and DLB, and to develop clinically applicable biomarkers for stratifying the dementias according to underlying molecular patterns.
During 2024, the Dementia Node made key advances in their clinical research projects, which include one clinical trial and one prospective cohort study.
See an overview of all Neuro-SysMed's dementia projects on the page Dementia and clinical studies.